when will retatrutide be approved - Find Top Weight Loss Doctors Near You The FDA has issued warning
Description
While clinical trials show adults on the highest dose of Zepbound lose an average of 22.5% of their body weight after 72 weeks (when paired with diet and exercise), recent Phase 3 trial data (from the TRIUMPH-1 study released in May 2026) shows even better results
It is important to note that these metabolic adaptations are generally physiological responses to weight loss rather than pathological changes
Alzheimers Dement (2016) 12(6):71932
Jeong D, Priefer R
They help the body release insulin after meals and reduce excess glucagon, the hormone that raises blood sugar between meals
